Phibro Animal Health (PAHC) Stock Price, News & Analysis

Company Overview

Phibro Animal Health Corporation is a global animal health and mineral nutrition company providing a range of products and services to improve the health and performance of livestock, poultry, aquaculture and companion animals. The company’s portfolio encompasses feed additives, performance solutions, vaccines, and specialty mineral and nutrition products designed to support animal well-being, growth efficiency, and disease management. Phibro operates through multiple business platforms that address varying customer needs across different stages of animal production.

Phibro’s feed additives and performance products include ionophores, coccidiostats, organic trace minerals, anticoccidials and specialty oils that enhance feed conversion and nutritional uptake. Its biologics offerings feature vaccines and other immunological solutions to prevent common diseases in poultry and livestock, while the mineral nutrition segment delivers customized trace mineral premixes and chelated minerals tailored to specific dietary requirements. The company also serves the aquaculture sector with targeted solutions to support fish health and growth, as well as the companion animal market with select veterinary pharmaceuticals.

With origins dating back to the mid-20th century, Phibro has expanded through strategic acquisitions, joint ventures and ongoing research and development efforts. The firm maintains a global footprint, operating manufacturing facilities and R&D centers in the Americas, Europe, Asia Pacific, Middle East and Africa. This international presence enables Phibro to adapt its product offerings to regional regulatory frameworks, agricultural practices and market trends, while fostering collaborations with local partners and research institutions.

Phibro is led by an experienced senior management team committed to innovation, sustainability and operational excellence. Under the direction of its Executive Chairman and Chief Executive Officer, the company continues to invest in new technologies, expand its geographic reach and strengthen customer relationships. Through a balanced approach to growth—combining internal product development with strategic acquisitions—Phibro seeks to uphold its reputation as a trusted provider of animal health and nutrition solutions worldwide.

Key Stats

• Today's Range: $30.15 to $30.98
• 50-Day Range: $19.04 to $31.39
• 52-Week Range: $16.16 to $31.80
• Volume: 330,261 shs
• Average Volume: 220,581 shs
• Market Capitalization: $1.25 billion
• P/E Ratio: 39.49
• Dividend Yield: 1.56%
• Price Target: $24.40
• Consensus Rating: Reduce

Phibro Animal Health Stock Analysis - MarketRank™

Phibro Animal Health scored higher than 81% of companies evaluated by MarketBeat, and ranked 216th out of 944 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 0.9 / 5
• Analyst Rating: Reduce

Consensus Rating

Phibro Animal Health has received a consensus rating of Reduce. The company's average rating score is 1.83, and is based on 1 buy rating, 3 hold ratings, and 2 sell ratings.

Amount of Analyst Coverage

Phibro Animal Health has only been the subject of 4 research reports in the past 90 days.

Earnings and Valuation

• Score: 2.5 / 5
• Proj. Earnings Growth: 7.69%

Earnings Growth

Earnings for Phibro Animal Health are expected to grow by 7.69% in the coming year, from $1.95 to $2.10 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Phibro Animal Health is 39.49, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 25.92.

Price to Earnings Ratio vs. Sector

The P/E ratio of Phibro Animal Health is 39.49, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 28.10.

Price to Earnings Growth Ratio

Phibro Animal Health has a PEG Ratio of 0.52. PEG Ratios below 1 indicate that a company could be undervalued.

Price to Book Value per Share Ratio

Phibro Animal Health has a P/B Ratio of 4.86. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Short Interest

• Score: 4.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

4.68% of the float of Phibro Animal Health has been sold short.

Short Interest Ratio / Days to Cover

Phibro Animal Health has a short interest ratio ("days to cover") of 3.6, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Phibro Animal Health has recently decreased by 4.62%, indicating that investor sentiment is improving.

Dividend

• Score: 2.5 / 5
• Dividend Strength: Moderate

Dividend Yield

Phibro Animal Health pays a meaningful dividend of 1.54%, higher than the bottom 25% of all stocks that pay dividends.

Dividend Growth

Phibro Animal Health does not have a long track record of dividend growth.

Dividend Coverage

The dividend payout ratio of Phibro Animal Health is 61.54%. This payout ratio is at a healthy, sustainable level, below 75%.

Dividend Sustainability

Based on earnings estimates, Phibro Animal Health will have a dividend payout ratio of 22.86% next year. This indicates that Phibro Animal Health will be able to sustain or increase its dividend.

Sustainability and ESG

• Score: 1.1 / 5
• Environmental Score: -3.93

Percentage of Shares Shorted

4.68% of the float of Phibro Animal Health has been sold short.

Short Interest Ratio / Days to Cover

Phibro Animal Health has a short interest ratio ("days to cover") of 3.6, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Phibro Animal Health has recently decreased by 4.62%, indicating that investor sentiment is improving.

News and Social Media

• Score: 3.1 / 5
• News Sentiment: 0.66

News Sentiment

Phibro Animal Health has a news sentiment score of 0.66. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 1.00 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 14 news articles for Phibro Animal Health this week, compared to 4 articles on an average week.

Search Interest

13 people have searched for PAHC on MarketBeat in the last 30 days. This is an increase of 550% compared to the previous 30 days.

MarketBeat Follows

10 people have added Phibro Animal Health to their MarketBeat watchlist in the last 30 days.

Company Ownership

• Score: 3.3 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Phibro Animal Health insiders have not sold or bought any company stock.

Percentage Held by Insiders

50.07% of the stock of Phibro Animal Health is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

99.34% of the stock of Phibro Animal Health is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

PAHC Stock Analysis - Frequently Asked Questions

How have PAHC shares performed this year?

Phibro Animal Health's stock was trading at $21.00 at the beginning of the year. Since then, PAHC stock has increased by 46.7% and is now trading at $30.80.

How were Phibro Animal Health's earnings last quarter?

Phibro Animal Health Corporation (NASDAQ:PAHC) issued its earnings results on Wednesday, May, 7th. The company reported $0.63 EPS for the quarter, beating analysts' consensus estimates of $0.52 by $0.11. The company had revenue of $347.80 million for the quarter, compared to analyst estimates of $352.41 million. Phibro Animal Health had a net margin of 2.68% and a trailing twelve-month return on equity of 30.51%.
Read the conference call transcript.

Who are Phibro Animal Health's major shareholders?

Phibro Animal Health's top institutional investors include Kings Path Partners LLC (0.05%) and Harbor Capital Advisors Inc. (0.02%).
View institutional ownership trends.

How do I buy shares of Phibro Animal Health?

Shares of PAHC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Phibro Animal Health own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Phibro Animal Health investors own include Solid Power (SLDP), Meta Platforms (META), Tesla (TSLA), JPMorgan Chase & Co. (JPM), NVIDIA (NVDA), AT&T (T) and Advanced Micro Devices (AMD).

Company Calendar

• Last Earnings: 5/07/2025
• Record date for 6/25 Dividend: 6/04/2025
• Ex-Dividend for 6/25 Dividend: 6/04/2025
• Dividend Payable: 6/25/2025
• Today: 7/12/2025
• Next Earnings (Estimated): 8/27/2025
• Fiscal Year End: 6/30/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: MED PRODUCTS
• Sub-Industry: Pharmaceutical Products
• Current Symbol: NASDAQ:PAHC
• CIK: 1069899
• Web: www.pahc.com
• Phone: (201) 329-7300
• Fax: 201-329-7399
• Employees: 1,940
• Year Founded: N/A

Price Target and Rating

• Average Price Target for Phibro Animal Health: $24.40
• High Price Target: $35.00
• Low Price Target: $15.00
• Potential Upside/Downside: -20.8%
• Consensus Rating: Reduce
• Rating Score (0-4): 1.83
• Research Coverage: 6 Analysts

Profitability

• EPS (Trailing Twelve Months): $0.78
• Trailing P/E Ratio: 39.49
• Forward P/E Ratio: 15.79
• P/E Growth: 0.52
• Net Income: $2.42 million
• Net Margins: 2.68%
• Pretax Margin: 4.25%
• Return on Equity: 30.51%
• Return on Assets: 6.89%

Debt

• Debt-to-Equity Ratio: 2.67
• Current Ratio: 2.91
• Quick Ratio: 1.23

Sales & Book Value

• Annual Sales: $1.02 billion
• Price / Sales: 1.23
• Cash Flow: $2.09 per share
• Price / Cash Flow: 14.73
• Book Value: $6.34 per share
• Price / Book: 4.86

Miscellaneous

• Outstanding Shares: 40,530,000
• Free Float: 20,239,000
• Market Cap: $1.25 billion
• Optionable: Optionable
• Beta: 0.75